Recent Updates
Recently added Catalysts
KIDS Positive Sentiment Score: 60/100

OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023

Key Takeaway: OrthoPediatrics Corp. has announced that it will report its third quarter 2023 financial results on November 6, 2023, after the market closes. A conference call to discuss these results is scheduled for November 7, 2023, at 8:00 a.m. ET. The company, which specializes in pediatric orthopedics, has developed a wide range of surgical systems intended to improve treatment for children with orthopedic conditions. Their products are marketed globally, reaching both the U.S. and over 70 other countries.

Market Sentiment Analysis

POSITIVE FACTORS

  • OrthoPediatrics is focused exclusively on pediatric orthopedics.
  • The company will release its financial results soon, indicating progress.
  • They have a comprehensive product offering across multiple surgical categories.

Full Press Release Details

WARSAW, Ind., Oct. 17, 2023 (GLOBE NEWSWIRE) --  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2023 financial results on Monday, November 6, 2023, after the market closes. OrthoPediatrics will host a conference call on Tuesday, November 7, 2023, at 8:00 a.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 52 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Frequently Asked Questions

When will OrthoPediatrics announce its Q3 2023 financial results?

OrthoPediatrics will release its Q3 2023 financial results on November 6, 2023.

What time is the conference call for Q3 results?

The conference call will be held on November 7, 2023, at 8:00 a.m. ET.

How can I access the conference call webcast?

Investors can access the webcast on OrthoPediatrics' Investors page.

How long will the webcast be available for replay?

The webcast will be available for replay for at least 90 days.

What products does OrthoPediatrics offer?

OrthoPediatrics markets 52 surgical systems for pediatric orthopedic conditions.

Last updated: Oct 17, 2023